AI assistant
Sending…
Athira Pharma, Inc. — Director's Dealing 2023
May 22, 2023
35038_dirs_2023-05-22_a10c40ed-4ddc-4b19-9a72-a238476ddab3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Athira Pharma, Inc. (ATHA)
CIK: 0001620463
Period of Report: 2023-05-18
Reporting Person: Gengos Andrew (See Below)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| No securities are beneficially owned | 0 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| No securities are beneficially owned | $0.00 | Not applicable (0) | Direct |
Footnotes
F1: Not applicable
More from Athira Pharma, Inc.
Annual Report
2026
May 11
Registration Form
2026
Apr 1
Registration Form
2026
Mar 31
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 19
Proxy Solicitation & Information Statement
2026
Feb 23
Major Shareholding Notification
2026
Feb 6
Registration Form
2026
Jan 20
Registration Form
2026
Jan 20